The algorithm gathers data from wearable monitors to find life-threatening irregular heartbeats and allows for data to be sorted through in remote areas where there is a scarcity of cardiologists.
“One of the big deals about this work, in my opinion, is not just that we do abnormality detection but that we do it with high accuracy across a large number of different types of abnormalities,” said Awni Hannun, a graduate student and co-lead author of the paper, in a press release. “This is definitely something that you won’t find to this level of accuracy anywhere else.”
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.